These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 1502858)

  • 1. [Plasma GM-CSF concentrations in rheumatoid arthritis, systemic lupus erythematosus and spondyloarthropathy].
    Fiehn C; Wermann M; Pezzutto A; Hüfner M; Heilig B
    Z Rheumatol; 1992; 51(3):121-6. PubMed ID: 1502858
    [TBL] [Abstract][Full Text] [Related]  

  • 2. G-CSF and GM-CSF concentrations and receptor expression in peripheral blood leukemic cells from patients with chronic myelogenous leukemia.
    Lee J; Kim Y; Lim J; Kim M; Han K
    Ann Clin Lab Sci; 2008; 38(4):331-7. PubMed ID: 18988925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Granulocyte and granulocyte-macrophage colony-stimulating factors, their receptors and interleukin-3 levels in newborns.
    Coşkun M; Kardelen F; Oygür N; Undar L; Savaş A; Yeğin O
    Turk J Pediatr; 1997; 39(3):295-301. PubMed ID: 9339107
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma profiles of circulating granulocyte-macrophage colony-stimulating factor and soluble cellular adhesion molecules in acute myocardial infarction. Contribution to post-infarction left ventricular dysfunction.
    Parissis JT; Adamopoulos S; Venetsanou K; Kostakis G; Rigas A; Karas SM; Kremastinos D
    Eur Cytokine Netw; 2004; 15(2):139-44. PubMed ID: 15319174
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autoantibodies against granulocyte-macrophage colony stimulating factor and interleukin-3 are rare in patients with Felty's syndrome.
    Hellmich B; Ciaglo A; Schatz H; Coakley G
    Ann Rheum Dis; 2004 Jul; 63(7):862-6. PubMed ID: 15194585
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytokines in chronic inflammatory arthritis. VI. Analysis of the synovial cells involved in granulocyte-macrophage colony-stimulating factor production and gene expression in rheumatoid arthritis and its regulation by IL-1 and tumor necrosis factor-alpha.
    Alvaro-Gracia JM; Zvaifler NJ; Brown CB; Kaushansky K; Firestein GS
    J Immunol; 1991 May; 146(10):3365-71. PubMed ID: 2026869
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lymph draining from foot joints in rheumatoid arthritis provides insight into local cytokine and chemokine production and transport to lymph nodes.
    Olszewski WL; Pazdur J; Kubasiewicz E; Zaleska M; Cooke CJ; Miller NE
    Arthritis Rheum; 2001 Mar; 44(3):541-9. PubMed ID: 11263768
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hematopoietic growth factors in patients receiving intensive chemotherapy for malignant disorders: studies of granulocyte-colony stimulating factor (G-CSF), granulocyte-macrophage colony stimulating factor (GM-CSF), interleukin-3 (IL-3) and Flt-3 ligand (Flt3L).
    Bruserud O; Foss B; Petersen H
    Eur Cytokine Netw; 2001; 12(2):231-8. PubMed ID: 11399510
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Plasma granulocyte-macrophage colony stimulating factor (GM-CSF) and activity of enzymes in granulocytes of breast cancer patients].
    Czygier M; Ławicki S; Szmitkowski M; Mroczko B
    Przegl Lek; 2006; 63(8):654-7. PubMed ID: 17441377
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recombinant human granulocyte-macrophage colony-stimulating factor therapy and endogenous plasma GM-CSF, IL-3, IL-4 concentrations in pediatric patients with solid tumors.
    Cetingül N; Kütükçüler N; Kantar M; Kavakli K; Nişli G; Cağlayan S; Oztop S
    Turk J Pediatr; 1997; 39(4):473-81. PubMed ID: 9433149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence for GM-CSF receptor expression in synovial tissue. An analysis by semi-quantitative polymerase chain reaction on rheumatoid arthritis and osteoarthritis synovial biopsies.
    Berenbaum F; Rajzbaum G; Amor B; Toubert A
    Eur Cytokine Netw; 1994; 5(1):43-6. PubMed ID: 8049356
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Granulocyte-macrophage colony stimulating factor and interleukin-6 enhanced white blood cell synthesis of leukotrienes in chronic myelogenous leukemia.
    el-Ahmady O; Mansour M; Kamel H; Baker A
    Anticancer Res; 1997; 17(4B):3179-82. PubMed ID: 9329631
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum levels of granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor in treated patients with chronic myelogenous leukemia in chronic phase.
    Balleari E; Bason C; Visani G; Gobbi M; Ottaviani E; Ghio R
    Haematologica; 1994; 79(1):7-12. PubMed ID: 15378942
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of activated cytokine pathways in the blood of systemic lupus erythematosus, myositis, rheumatoid arthritis, and scleroderma patients.
    Higgs BW; Zhu W; Richman L; Fiorentino DF; Greenberg SA; Jallal B; Yao Y
    Int J Rheum Dis; 2012 Feb; 15(1):25-35. PubMed ID: 22324944
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The plasma levels of granulocyte-colony stimulating factor and granulocyte-macrophage colony stimulating factor in breast cancer patients].
    Ławicki S; Czygier M; Omyła J; Bedkowska E; Szmitkowski M
    Pol Merkur Lekarski; 2007 Oct; 23(136):259-63. PubMed ID: 18293847
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Leukocyte numbers correlate with plasma levels of granulocyte-macrophage colony-stimulating factor in sickle cell disease.
    Conran N; Saad ST; Costa FF; Ikuta T
    Ann Hematol; 2007 Apr; 86(4):255-61. PubMed ID: 17205286
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of granulocyte-macrophage colony-stimulating factor in Philadelphia (Ph1)-positive acute lymphoblastic leukemia: studies on two newly established Ph1-positive acute lymphoblastic leukemia cell lines (Z-119 and Z-181).
    Estrov Z; Talpaz M; Zipf TF; Kantarjian HM; Ku S; Ouspenskaia MV; Hirsch-Ginsberg C; Huh Y; Yee G; Kurzrock R
    J Cell Physiol; 1996 Mar; 166(3):618-30. PubMed ID: 8600166
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Soluble TRAIL concentrations are raised in patients with systemic lupus erythematosus.
    Lub-de Hooge MN; de Vries EG; de Jong S; Bijl M
    Ann Rheum Dis; 2005 Jun; 64(6):854-8. PubMed ID: 15564310
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autoantibodies against granulocyte colony-stimulating factor in Felty's syndrome and neutropenic systemic lupus erythematosus.
    Hellmich B; Csernok E; Schatz H; Gross WL; Schnabel A
    Arthritis Rheum; 2002 Sep; 46(9):2384-91. PubMed ID: 12355486
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of the activity of a human granulocyte-macrophage colony-stimulating factor/interleukin-3 fusion protein (pIXY 321) by the macrocyclic lactone protein kinase C activator bryostatin 1.
    McCrady CW; Li F; Pettit GR; Grant S
    Exp Hematol; 1993 Jul; 21(7):893-900. PubMed ID: 7686503
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.